Congress Questions Results Of Cholesterol Study
A U.S. House of Representatives committee is investigating Merck & Co. Inc. and Schering-Plough Corp. for their delay in releasing the results of a clinical trial for cholesterol drug Vytorin....To view the full article, register now.
Already a subscriber? Click here to view full article